Takeda Pharmaceutical's revenue in the U.S. FY 2018-2022
In fiscal year 2022, the revenue generated in the United States of Takeda Pharmaceutical Co., Ltd. accounted for approximately 2.1 trillion Japanese yen, marking the highest revenue over a five-year period. In contrast, the company's revenue in the U.S. in fiscal year 2018 amounted to around 829 billion yen.